ADD Doctor
Behavioral Disorder: Nancy Worthington, MD
Mrs. H. called the office in tears requesting an urgent behavioral treatment consult for her six year old son, C.H. Despite almost a year of behavioral interventions at kindergarten and at home, C.H. remained oppositional, aggressive, insistent and persistent. His mood would flare without warning and meltdowns were intense and exhausting. His school progress was hindered by his tendency to interrupt, disrupt, “goof off” and not follow directions. C.H. was not good at taking turns, respecting personal space or sharing. He was an unhappy little fellow without a good friend.
On this particular morning, C.H. had been throwing things, hit his mother and sister and had a meltdown over the breakfast cereal choice. Despite it being a school holiday, Mrs. H. had brought C.H. to his after school day care center because she “just couldn’t take it anymore”. Though Mrs. H. felt like a terrible mother, I knew the opposite to be the truth. I had been the family’s Pediatrician since C.H.’s birth and I was always impressed by the mother’s patience, firmness and common sense approach with dealing with her difficult, temperamental son. Up to this point, Mrs. H. had firmly rejected the idea of any medical intervention but today she was open to any suggestions. Upon further discussion, C.H.’s observed behaviors were best explained by decreased neurotransmitter (serotonin, dopamine, or norepinephrine) function: ADD, anxiety, obsession, aggression, and poor sleep.
C.H. was started on the NeuroResearch pediatric 5-HTP, tyrosine, levodopa, and cysteine protocol. Nine days after treatment was started a notably happy, calm, polite and cooperative little red-head returned for a follow-up visit. He stayed seated on the bench while his mother (also happy and smiling) described the past few days as “GREAT”!, something she admitted she thought she would never be able to say. One month later, C.H. came in bringing his pill calendar and wearing his big smile. He was now sleeping through the night and waking easily in the morning. School was progressing very well now that his bright mind and inquisitive personality were present. His teacher had just recommended testing for placement in the gifted program for first grade. Mrs. H. was actually looking forward to the next school holiday with anticipation and C.H. couldn’t wait for the weekend to join a friend for a play date.
This week, C.H. started first grade after a busy “normal” summer. He qualified for placement in the gifted program at his public school and we are anticipating a great year!
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa, and cysteine for treatment by the ADD doctor in order to get these results. Proper use of these simple ingredients in medical treatment is not simple. From time to time a patient will say, "Why do I want to take that, I can go to a health food store and buy it?" People off the street buying in a health food store is like going to an art store and buying a bunch of oil paints then going home and expecting to paint like a mater artist even though there was no previous painting experience. These nutrients have tremendous potential due to their chemical properties. This potential is only fully realized in the hands of the trained professional using neurotransmitter testing. Treatment is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The ADD doctor research findings of NeuroResearch Clinics have not been ignored. The University of Minnesota Medical School is writing a series of papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid Kohlstadt, MD of Johns Hopkins in her new medical text book released February 7, 2009 included a chapter on depression written by Marty L. Hinz, MD President Clinical Research NeuroResearch Clinics outlining in depth the proper use of amino acids and neurotransmitter testing in treatment of depression.
